Phage Therapy – Information Night for Adults with CF

Phage Therapy – Information Evening for Adults with CF

Phage therapy, a promising candidate for treating bacterial infections that have become resistant to conventional antibiotics

Join us for the upcoming Phage Information Evening for adults with CF.

Phages and Phage Therapy

Phages are viruses that infect and kill bacteria and are highly specific to their host bacteria, so offer many advantages over antibiotics as a treatment option. Work conducted at Telethon Kids Institute has led to the isolation of many phages specific for different clinical isolates of Pseudomonas aeruginosa, with a collection of phages specific for Staphylococcus aureus also amassing. Phage therapy has been used successfully in various locations across the world and more recently has been used on compassionate grounds in NSW; but has not yet been used in WA.

Phage Therapy Task Force

Here in WA we have taken the first steps towards phage therapy use by forming a Phage Therapy Task Force (START Phage). The goal of this task force is to have the first WA patient treated with phage as soon as possible.

At this Phage Therapy Information Night, we invite you to hear from task force members Associate Professor Anthony Kicic (Head, Airway Epithelial Research Group, Telethon Kids Institute), Dr Anna Tai (Adult Respiratory Physician, Sir Charles Gardner Hospital) and Professor Stephen Stick (Director, Wal-yan Respiratory Research Centre) on the scientific and clinical implications of phage therapy.


Date: Wednesday 4 August 2021
Time: 7pm
RSVP: Please RSVP to Angela.Fuery@telethonkids.org.au by Friday 30 July (a meeting invitation will be sent to you following RSVP).

Please note this will be an online event, you will need a computer or mobile device with internet access in order to participate.

We look forward to providing you with some information about this and answering any questions or concerns that you may have.

2022 © Cystic Fibrosis Western Australia Privacy Policy | Refund & Delivery Policy | ABN: 19 156 339 182